Cengild Medical Berhad (0243) — Strategic Asset Allocation Index
Cengild Medical Berhad (0243) has a Strategic Asset Allocation Index of 22.5% as of June 2023. Strategic assets (PP&E of RM23.89 Million plus long-term investments of RM-) total RM23.89 Million, measured against net assets of RM106.11 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See Cengild Medical Berhad balance sheet quality to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
Cengild Medical Berhad Strategic Asset Allocation Index (2020–2023)
This chart shows how Cengild Medical Berhad's Strategic Asset Allocation Index has evolved across 4 annual periods from 2020 to 2023. As of June 2023, the index stands at 22.5%, representing strategic assets of RM23.89 Million against net assets of RM106.11 Million MYR. For live market cap and overall valuation, see market cap of Cengild Medical Berhad.
Annual Strategic Asset Allocation Index for Cengild Medical Berhad (2020–2023)
The table below presents the year-by-year Strategic Asset Allocation Index for Cengild Medical Berhad from 2020 to 2023, covering 4 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. See 0243 net assets for net asset value and shareholders' equity analysis.
| Year | SAAI | Strategic Assets (MYR) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2023 | 22.5% | RM23.89 Million | RM23.89 Million | RM- | RM106.11 Million | ▼ -3.7 pp |
| 2022 | 26.2% | RM24.35 Million | RM24.35 Million | RM- | RM92.95 Million | ▼ -215.6 pp |
| 2021 | 241.8% | RM33.32 Million | RM33.32 Million | RM- | RM13.78 Million | ▼ -130.9 pp |
| 2020 | 372.7% | RM36.48 Million | RM36.48 Million | RM- | RM9.79 Million | — |